Literature DB >> 17959655

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.

Leslie T Cooper1, Kenneth L Baughman, Arthur M Feldman, Andrea Frustaci, Mariell Jessup, Uwe Kuhl, Glenn N Levine, Jagat Narula, Randall C Starling, Jeffrey Towbin, Renu Virmani.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17959655     DOI： 10.1161/CIRCULATIONAHA.107.186093

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  194 in total

1.  Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy.

Authors:  Anamaria Wolf-Puetz; Matthias Wein; Reinhard Niehues; Marc Horlitz; Malte Kelm; Karin Klingel; Reinhard Kandolf; Rolf Michael Klein
Journal:  Clin Res Cardiol       Date:  2010-12-03       Impact factor: 5.460

Review 2.  [Comorbidity oriented oncology - an overview].

Authors:  Ralph Simanek; Michael Wuensch; Roland Edlinger; Bernhard Hammerl-Ferrari; Ludwig Kramer; Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

Review 3.  What's new in myocarditis?

Authors:  Charles-Edouard Luyt; Guillaume Hékimian; Fredric Ginsberg
Journal:  Intensive Care Med       Date:  2015-08-14       Impact factor: 17.440

4.  Feasibility of real-time magnetic resonance imaging-guided endomyocardial biopsies: An in-vitro study.

Authors:  Dirk Lossnitzer; Sebastian A Seitz; Birgit Krautz; Bernhard Schnackenburg; Florian André; Grigorios Korosoglou; Hugo A Katus; Henning Steen
Journal:  World J Cardiol       Date:  2015-07-26

5.  Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis.

Authors:  John P Bois; Panithaya Chareonthaitawee
Journal:  J Nucl Cardiol       Date:  2015-08-13       Impact factor: 5.952

Review 6.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 7.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

8.  Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

Authors:  Scot J Matkovich; Derek J Van Booven; Keith A Youker; Guillermo Torre-Amione; Abhinav Diwan; William H Eschenbacher; Lisa E Dorn; Mark A Watson; Kenneth B Margulies; Gerald W Dorn
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

9.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

Review 10.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.